Defining dysplasia in Barrett esophagus

Area of Science:

• Gastroenterology
• Pathology
• Oncology

Background:

• Histologic grading of esophageal biopsies is essential for managing Barrett esophagus.
• Despite research into genetic abnormalities, no objective tests currently replace pathologist interpretation for prognosis.
• Histologic interpretation is subjective and relies heavily on pathologist experience.

Purpose of the Study:

• To present updated pathologic criteria for dysplasia grading in Barrett esophagus.
• To review results from two large interobserver variability studies on dysplasia grading.
• To emphasize the utility of histologic grading when established criteria are followed.

Main Methods:

• Review of updated pathologic criteria for esophageal biopsy grading.
• Analysis of findings from two interobserver variability studies.
• Discussion of the subjective nature and reliance on pathologist experience in histologic interpretation.

Main Results:

• Published criteria, when followed, support the utility of histologic grading of dysplasia in Barrett esophagus.
• Interobserver variability studies indicate that standardized criteria enhance the reliability of grading.
• Pathologist experience remains a critical factor in accurate histologic interpretation.

Conclusions:

• Histologic grading of esophageal biopsies remains a cornerstone in Barrett esophagus management.
• Adherence to updated pathologic criteria and established guidelines improves grading reliability.
• While subjective, experienced pathologists using standardized criteria provide a valuable tool for patient prognosis and management.